158 results have been found
August 16, 2021
Grifols advances on its strategic investment from GIC with 90% of consents from its notes holders and lenders
August 11, 2021
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19
July 30, 2021
Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?